Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Interest Income | 177,109 |
| Interest Expense | 102,004 |
| Interest Income (Net of Interest Expense) | 75,105 |
| Non-Interest Income | 13,562 |
| Sales | 88,667 |
| Credit Losses Provision | 3,900 |
| Non Interest Expenses | 64,478 |
| Pre-tax Income | 20,289 |
| Income Tax | 7,470 |
| Other Income | 122,293 |
| Net Income | $12,819 |
| EPS Basic Continuous Ops | 43.19 |
| EPS Basic Total Ops | 43.17 |
| EPS Diluted Continuous Ops | 42.85 |
| EPS Diluted Total Ops | 42.84 |
| EBITDA(a) | $N/A |